SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Bristol Myers Squibb
Bristol Myers Squibb
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By
Lindsey Leake
February 7, 2025
Health
20 innovative breakthroughs that will transform your health
By
Erika Fry
December 18, 2024
Commentary
Developing new medicines for everyone, everywhere, equally
By
Giovanni Caforio, MD
November 13, 2023
Newsletters
Here’s what differentiates the top 25 corporate boards from their counterparts
By
Lila MacLellan
May 12, 2023
Leadership
These 25 companies have the most ‘modern’ boards. Here’s what that means
By
Lila MacLellan
May 10, 2023
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By
Jeremy Kahn
and
Jonathan Vanian
January 25, 2022
Conferences
Leaders from Peloton, Chobani, and more on how brands earn their purpose
By
Lydia Belanger
October 13, 2021
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Sy Mukherjee
August 5, 2021
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By
Jeremy Kahn
June 15, 2021
Health
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By
Harris Meyer
and
Kaiser Health News
December 28, 2020
Finance
Warren Buffett is going all in on the vaccine rally, piling into these stocks
By
Katherine Chiglinsky
and
Bloomberg
November 17, 2020
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By
Sy Mukherjee
October 1, 2020
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg